Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat sodium for trauma-associated ARDS
ChiCTR2400091027Phase 4Recruiting
- Sponsor
- Fourth Medical Center of PLA General Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sivelestat in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Fourth Medical Center of PLA General Hospital. Primary endpoint: Oxygenation index. Started Oct 2024; status: recruiting.
02
Drugs
sivelestat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2400091027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091027.